Monthly Archives: June 2012

Daily ETF Roundup: VXX Pops On Sour Retail Sales, XHB Heads South

Posted on by

Today was yet another roller coaster ride for markets; equities quickly sold off the previous sessions gains in the morning, only to claw back towards positive territory, then finally tumble into the red yet again at closing. Sour U.S. retail sales data coupled with ongoing Euro Zone worries quickly eroded investors confidence in the push towards a global economic recovery; the Dow Jones Industrial Average shed 77.42 points or 0.62%, while the S&P 500 fell 0.7%, and Nasdaq settled at the bottom of the barrel with a 0.86% loss [see also101 ETF Lessons Every Financial Advisor Should Learn].

U.S. retail sales fell yet again in May, slipping 0.2% and prompting the firststringof declines in nearly two years. Although this latest report paints a rather grim picture for the consumer discretionary sector, automobile sales were reported to be up 0.8% as Americans bought 1,334,600 new vehicles in the month of May. While investors digest the latest U.S. data, they will continue to keep a close eye on the Euro Zone as the Spanish bailout plan continues to unfold and Greece prepares for its elections this coming weekend [seeETF Technical Trading FAQ].

The Barclays iPath S&P 500 VIX Short-Term Futures ETN (VXX) was one of the best performers, gaining 5.15% on the day. VXX gapped higher at the start of the trading session only to charge even higher after a slight mid-morning dip. Higher levels of volatility prompted by sour U.S. data and continuing Euro Zone drama bolstered this ETF to close near its high today just shy of $20.93 a share[seeThe Compelling (And Simple) Case For Low Volatility ETFs].

The State Street SPDR Homebuilders ETF (XHB) was one of the worst performers, shedding 2.20% on the day. As fear and uncertainty crept back into the markets, this ETF slid lower as investors shied away from riskier asset classes, shifting exposure towards safer segments of the market, including U.S. Treasuries [see also2012 ETFdb Portfolio].

Follow me on Twitter@DPylypczak

[For more ETF analysis, make sure to sign up for ourfree ETF newsletteror try afree seven day trial to ETFdb Pro]

Disclosure: No positions at time of writing.

Click here to read the original article on ETFdb.com.

Go here to read the rest:

Daily ETF Roundup: VXX Pops On Sour Retail Sales, XHB Heads South

Blake 'BILKO' Williams heads to Turkey for Rd3 of Red Bull X-Fighters

Posted on by

Williams is one of two Aussies in action amongst the 12-rider lineup featuring freestyle motocross most-credentialed athletes.

Williams was a consistent player on the Red Bull X-Fighters tour last year, making the podium in Spain and finishing fourth in Italy and Dubai.

He finished the year in fifth place on the standings, but has not scored a point in competition this year after being forced out of the Dubai opener with injury.

Rival riders will be wary of the former X Games gold medallist, renowned for his signature style and ability to pull off the biggest tricks when called upon.

Back in action this weekend is fellow Aussie Rob Adelberg, who rode with a broken jaw at last months Glen Helen event in the United States.

Adelberg fought gallantly but struggled against the local riders, and was unable to repeat his podium performance from the opening round in Dubai where he finished a strong second.

The Yamaha-mounted rider still collected 35 points for his efforts, and, added to his 80 from round 1, holds down fourth place on the world tour standings.

American rider Todd Potter leads the way on 135 points ahead of New Zealands Levi Sherwood.

In competition, riders will face off in pairs to determine those who will contest quarter, semi and the eventual grand finals.

A panel of five expert judges will score them in areas of variety, challenge and execution, form and flow, use of course and energy, excitement and entertainment.

Excerpt from:

Blake 'BILKO' Williams heads to Turkey for Rd3 of Red Bull X-Fighters

China's Red Ants welcome at RV picnic

Posted on by

BEIJING (Reuters) - Dong Xuemin can't wait for weekends when he heads out with family or friends to the mountains north of Beijing or to a lake for a picnic. Dong is a "Red Ant" - a member of a club of urban Chinese who'll find any excuse to hit the road, not in ordinary cars, but in recreational vehicles, those quintessential Western chariots of leisure transportation used by "Snowbirds" in ...

See the article here:

China's Red Ants welcome at RV picnic

NASA | Five Teachers, 500 Meters Above Greenland – Video

Posted on by

13-06-2012 09:48 This year five teachers were invited on board NASA's P-3B aircraft to fly at 500 meters above the glaciers of Greenland with Operation IceBridge, a six-year mission to study Arctic and Antarctic ice. Two teachers from Greenland, two from Denmark, and one from the United States were given the opportunity to see polar research first hand, and then take that experience back to their classrooms. This video is public domain and can be downloaded at: Like our videos? Subscribe to NASA's Goddard Shorts HD podcast: Or find NASA Goddard Space Flight Center on facebook: Or find us on Twitter:

Go here to see the original:

NASA | Five Teachers, 500 Meters Above Greenland - Video

NASA's NuSTAR mission lifts off

Posted on by

ScienceDaily (June 13, 2012) NASA's Nuclear Spectroscopic Telescope Array (NuSTAR) launched into the morning skies over the central Pacific Ocean at 9 a.m. PDT (noon EDT) Wednesday, beginning its mission to unveil secrets of buried black holes and other exotic objects.

"We all eagerly await the launch of this novel X-ray observatory," said Paul Hertz, NASA's Astrophysics Division Director. "With its unprecedented spatial and spectral resolution to the previously poorly explored hard X-ray region of the electromagnetic spectrum, NuSTAR will open a new window on the universe and will provide complementary data to NASA's larger missions, including Fermi, Chandra, Hubble and Spitzer."

NuSTAR will use a unique set of eyes to see the highest energy X-ray light from the cosmos. The observatory can see through gas and dust to reveal black holes lurking in our Milky Way galaxy, as well as those hidden in the hearts of faraway galaxies.

"NuSTAR will help us find the most elusive and most energetic black holes, to help us understand the structure of the universe," said Fiona Harrison, the mission's principal investigator at the California Institute of Technology in Pasadena.

The observatory began its journey aboard a L-1011 "Stargazer" aircraft, operated by Orbital Sciences Corporation, Dulles, Va. NuSTAR was perched atop Orbital's Pegasus XL rocket, both of which were strapped to the belly of the Stargazer plane. The plane left Kwajalein Atoll in the central Pacific Ocean one hour before launch. At 9:00:35 a.m. PDT (12:00:35 p.m. EDT), the rocket dropped, free-falling for five seconds before firing its first-stage motor.

About 13 minutes after the rocket dropped, NuSTAR separated from the rocket, reaching its final low Earth orbit. The first signal from the spacecraft was received at 9:14 a.m. PDT (12:14 p.m. EDT) via NASA's Tracking and Data Relay Satellite System.

"NuSTAR spread its solar panels to charge the spacecraft battery and then reported back to Earth of its good health," said Yunjin Kim, the mission's project manager at NASA's Jet Propulsion Laboratory in Pasadena, Calif. "We are checking out the spacecraft now and are excited to tune into the high-energy X-ray sky."

The mission's unique telescope design includes a 33-foot (10-meter) mast, which was folded up in a small canister during launch. In about seven days, engineers will command the mast to extend, enabling the telescope to focus properly. About 23 days later, science operations are scheduled to begin.

In addition to black holes and their powerful jets, NuSTAR will study a host of high-energy objects in our universe, including the remains of exploded stars; compact, dead stars; and clusters of galaxies. The mission's observations, in coordination with other telescopes such as NASA's Chandra X-ray Observatory, which detects lower-energy X-rays, will help solve fundamental cosmic mysteries. NuSTAR also will study our sun's fiery atmosphere, looking for clues as to how it is heated.

NuSTAR is a Small Explorer mission led by the Caltech and managed by JPL for NASA's Science Mission Directorate in Washington. The spacecraft was built by Orbital Sciences Corporation. Its instrument was built by a consortium including Caltech; JPL; the University of California, Berkeley; Columbia University, New York; NASA's Goddard Space Flight Center, Greenbelt, Md.; the Danish Technical University in Denmark; Lawrence Livermore National Laboratory, Livermore, Calif.; and ATK Aerospace Systems, Goleta, Calif. NuSTAR will be operated by UC Berkeley, with the Italian Space Agency providing its equatorial ground station located at Malindi, Kenya. The mission's outreach program is based at Sonoma State University, Rohnert Park, Calif. NASA's Explorer Program is managed by Goddard. JPL is managed by Caltech for NASA.

Read this article:

NASA's NuSTAR mission lifts off

NASA's Bolden Visits SpaceX To View Dragon Capsule

Posted on by

June 14, 2012

Image Caption: NASA Administrator Charles Bolden, left, congratulates SpaceX CEO and Chief Designer Elon Musk in front of the historic Dragon capsule that returned to Earth on May 31 following the first successful mission by a private company to carry supplies to the International Space Station. Bolden and Musk also thanked the more than 150 SpaceX employees working at the McGregor facility for their role in the historic mission. This image was taken on Wednesday, June 13, 2012 at the SpaceX facility in McGregor, Texas. Image Credit: NASA/Bill Ingalls

NASA Administrator Charles Bolden joined SpaceX CEO and Chief Designer Elon Musk at the SpaceX Rocket Development Facility in McGregor, Texas, Wednesday to see the first commercial space capsule to complete a mission to the International Space Station.

Bolden and Musk also thanked the more than 150 SpaceX employees working at the McGregor facility for their role in the historic mission. SpaceXs Dragon capsule made history May 31 when it returned to Earth after delivering supplies to the space station.

The Dragon capsule is a tangible example of the new era of exploration unfolding right now, NASA Administrator Charles Bolden said. Commercial space is becoming a reality as SpaceX and our other commercial partners look ahead to future missions to the space station and other destinations. I congratulate Elon Musk and the entire SpaceX team again for this historic milestone.

While on-site, Bolden had the opportunity to view some of the 1,367 pounds of cargo the spacecraft returned to Earth from the space station. Dragon is the only spacecraft capable of returning a significant quantity of science experiments and cargo from the station. Experiments will be given back to researchers hoping to gain new insights provided by the stations unique microgravity environment. The cargo was transferred to NASA June 13 and will be taken to the agencys Johnson Space Center in Houston for further processing.

Dragons journey to the station was SpaceXs second demonstration mission under NASAs Commercial Orbital Transportation Services Program (COTS), which provides investments intended to lead to regular resupply missions to the International Space Station and stimulate the commercial space industry in the United States. The mission began May 22 as the capsule launched from Cape Canaveral Air Force Station in Florida aboard a SpaceX Falcon 9 rocket. After its maneuverability and abort systems were tested, crew members of Expedition 31 aboard the station grappled the capsule and berthed it to the orbiting laboratory.

Dragon, its exterior scorched by the heat of re-entry, splashed down in the Pacific Ocean May 31. SpaceX recovered the capsule immediately and transported it to McGregor, where engineers unloaded cargo and removed hazardous materials. Dragon will be shipped to SpaceX Headquarters in Hawthorne, Calif., later this year.

On Thursday, Bolden and Musk will be at SpaceX Headquarters to see the Dragon spacecraft that flew the first COTS demonstration mission in December 2010, during which SpaceX became the first private company to recover a spacecraft after it orbited Earth. They also will see a prototype Dragon spacecraft being designed to carry astronauts to the space station as part of NASAs Commercial Crew Program.

For more information about NASAs COTS Program and SpaceX, visit: http://www.spacex.com

See more here:

NASA's Bolden Visits SpaceX To View Dragon Capsule

NASA's chief visits the Dragon's lair

Posted on by

Bill Ingalls / NASA

SpaceX's billionaire founder, Elon Musk, makes remarks at the microphone while NASA Administrator Charles Bolden sizes up the company's Dragon capsule on Wednesday at the SpaceX rocket test facility in McGregor, Texas. Wednesday's gathering marked the handover of the Dragon's cargo to NASA after last month's historic commercial mission to the International Space Station.

By Alan Boyle

In the wake of a history-making commercial space mission, NASA Administrator Charles Bolden and SpaceX's billionaire founder, Elon Musk, met up in Texas today for a close-up look at the company's recently returned Dragon space capsule and the official handover of more than a half-ton of cargo that came back to Earth on the craft. Musk also got in a little Texas-style politicking on the side.

The SpaceX Dragon's trip to the International Space Station last month marked the first time a privately built craft made an orbital stopover. The Dragon is currently the only type of spaceship on the planet capable of bringing significant amounts of cargo back from the station up to 3 tons' worth. This time around, it returned 1,367 pounds (621 kilograms) of non-critical cargo, including scientific experiments as well as equipment and spacewalk gear that was no longer needed.

The handover at SpaceX's rocket development facility in McGregor, Texas, meant that the space agency and the 10-year-old company could check off the last major milestone on their list for the demonstration mission. And that, in turn, opens the way for SpaceX to start ferrying cargo to the station on a regular basis under the terms of a $1.6 billion contract with NASA. The first of 12 missions is tentatively planned for September.

Today's meeting gave Bolden and Musk an opportunity to thank the more than 150 SpaceX employees working at the McGregor facility and get a good look at the Dragon. The Associated Press quoted Musk as saying the craft looked "almost untouched," while Bolden said the capsule was "beaten up" during re-entry.

"The Dragon capsule is a tangible example of the new era of exploration unfolding right now," Bolden was quoted as saying in a NASA report about the Texas meet-up. "Commercial space is becoming a reality as SpaceX looks ahead to future missions to the space station and other destinations. All of NASA's partners in the commercial crew and cargo programs continue to meet milestones designing the next generation of innovative U.S.spacecraft destined for low Earth orbit. In addition, NASA centers across the country are making exciting progress on the vehicles that will take astronauts to farther destinations like an asteroid and Mars. I congratulate Elon Musk and the SpaceX team again for this historic milestone."

Bill Ingalls / NASA

NASA Administrator Charles Bolden, left, congratulates SpaceX CEO and Chief Designer Elon Musk in front of the Dragon capsule during Wednesday's meeting at the SpaceX facility in McGregor, Texas.

Originally posted here:

NASA's chief visits the Dragon's lair

NASA Launches Black Hole-Hunting Telescope

Posted on by

NASA's hunting season has just begun, as the U.S. space agency today launched its Nuclear Spectroscopic Telescope Array (NuSTAR) spacecraft into orbit on a quest for black holes.

Less than an hour after being flung out of the Earth's atmosphere (see video below), the advanced telescope was reportedly safely on its intended course and already prepping for its two-year mission to study the universe's black holes and remnants of supernova explosions.

With a fundamentally new, high-energy X-ray telescope, NASA will be able to see "the hottest, densest, and more energetic objects," with more high-definition images than ever before, according to Fiona Harrison, the NuSTAR principal investigator at the California Institute of Technology.

One of the first targets for the $165 million NuSTAR observatory is Cygnus X-1, a black hole in our own galaxy, according to William Craig, NuSTAR instrument manager at the University of California at Berkeley. The local black hole acts as a perfect point source for scientists to check the clarity of its images, Craig told according to Space.com.

"With NuSTAR, we'll be able to image the sky, read the story and understand things like how galaxies form, and how black holes grow," Harrison said during a Monday press briefing.

The telescope, which uses the same types of X-rays that doctors or airport security systems do, has more than 10 times the resolution and more than 100 times the sensitivity of its predecessors, while operating in a similar energy range, NASA said.

This won't be a solo mission for NuSTAR, though. Other space telescopes, including NASA's Chandra X-ray Observatory, will join hands with the new telescope to provide a more complete picture of what NASA calls "the most energetic and exotic objects in space."

Four years after its inception, the NuSTAR mission, which NASA's Astrophysics division director Paul Hertz called "low-cost" and a "modest investment," will provide "world-class science in an important but relatively unexplored band of the electromagnetic spectrum," Hertz said.

The NuSTAR mission has been awaiting liftoff since March, when the U.S. space agency delayed the launch pending a review of the rocket.

NASA last week scrapped a similar X-ray telescope project dubbed GEMS, or Gravity and Extreme Magnetism Small Explorer, due to budget constraints. Though still in the design stage, it cost the space agency $13 million to cancel the mission, which would have launched the machinery on a mission to look for black holes, neutron stars, and remnants of dead star systems.

See the original post here:

NASA Launches Black Hole-Hunting Telescope

Nano-Technologies Extended to Coax

Posted on by

Doug Lung / 06.14.2012 1:32PM

Nano-Technologies Extended to Coax

Nano-coaxial cable could be used as an energy storage device.

With all the research on nanotechnology, perhaps we shouldn't be surprised that one of the latest technologies to involve is coaxial cables on a nano-scale. The main interest in the nano-coaxial cable is as an energy storage device due to the very high capacitance between the inner and outer conductor.

The study found that the capacitance of the nanocable is at least 10 times greater than would be predicted with classical electrostatics. The capacitance of the new nanocable is up to 143 microfarads per centimeter-squared.

For energy storage, Lou envisioned a large scale energy storage device consisting of millions of tiny nanocables side by side in large areas.

Continue reading here:

Nano-Technologies Extended to Coax

Molecular Insight Pharmaceuticals Presents Clinical Oncology Data at Society of Nuclear Medicine 2012 Annual Meeting

Posted on by

CAMBRIDGE, MA--(Marketwire -06/14/12)- Molecular Insight Pharmaceuticals, Inc. today announced the presentation of nonclinical and clinical data at the Society of Nuclear Medicine 2012 Annual Meeting held June 9-13 in Miami Beach, Florida. The data were presented in seven oral sessions and five poster presentations and focused on the Company's small molecule approach to targeted radiotherapy and imaging of cancer, with particular emphasis on prostate cancer. These scientific presentations are available on the Company's website: http://www.molecularinsight.com/MolecularMedicine/ScientificPresentations.aspx

In a presentation titled "Small Molecule Inhibitors of Prostate Specific Membrane Antigen (PSMA) for SPECT: Summary of Phase 1 Studies in Patients with Prostate Cancer (PCa)" (Abstract 179), Dr. John W. Babich, President and Chief Scientific Officer, discussed how 123I and 99mTc-labeled small molecule PSMA inhibitors can rapidly detect metastatic prostate cancer in soft tissue and bone with high specificity and clearly visualize sub-centimeter lymph nodes. In this Phase 1 study, 123I-MIP-1072 planar and SPECT imaging were compared with 111In capromab pendetide images in a group of 24 advanced metastatic prostate cancer patients. Standard clinical endpoints of a prior documented prostate cancer diagnosis including clinical outcome, serial PSA levels, and CT and bone scans were used to define truth; biopsy confirmation of lesions detected radiographically was not included in this Phase 1 study. In 67% of subjects, a greater amount of tumor burden was observed by 123I-MIP-1072 imaging than in the same subjects imaged with 111In capromab pendetide. Additionally, there was agreement in 29% of subjects in which the 111In capromab pendetide and 123I-MIP-1072 estimated the same amount of tumor burden. The study also showed that 123I-MIP-1072 identified 20%-25% more subjects with at least one positive lesion than did 111In capromab pendetide. In addition, at the lesion level, upwards of 50% more lesions were identified as positive by 123I-MIP-1072 as compared to 111In capromab pendetide.

Also presented were the results of a separate study comparing the distribution, kinetics, and prostate cancer targeting of 99mTc-MIP-1404 and 99mTc-MIP-1405 in six patients with metastatic cancer and in six normal men. 99mTc- labeled MIP-1404 and MIP-1405 rapidly localized in bone and lymph node metastases as early as 1 hour post injection and both agents cleared rapidly from blood. Both agents identified a greater number of lesions than bone scans and rapidly detected soft tissue prostate cancer lesions including sub-centimeter lymph nodes. Non-significant uptake was seen in the prostate of normal men, though significantly lower urinary activity was seen with 99mTc-MIP-1404 than with 99mTc-MIP-1405. The lower urinary activity allows enhanced visualization of the prostate and lymph nodes in the lower pelvis making 99mTc-MIP-1404 the preferred agent for further development.

"In patients with metastatic prostate cancer, our clinical studies demonstrated that our technetium-99m-labeled compounds, particularly MIP-1404, rapidly localize to lesions in lymph nodes and bone on whole-body imaging as early as 1 hour post injection," noted Dr. Babich. "The study also showed there is a good correlation with bone scans in most subjects, but, in general, more lesions are visualized with 99mTc-MIP-1404 than with bone scan. With an increasing number of new therapies coming to market for the prostate cancer patient, visualizing disease earlier should help physicians make more rapid and informed decisions regarding the sequencing and use of this expanding group of drugs."

Dr. Babich continued, "Since our studies have demonstrated that 99mTc-MIP-1404 has less urinary excretion, and since better visualization of the prostate and surrounding lymph nodes is crucial in the imaging of prostate cancer, the Company plans to initiate a multi-center international Phase 2 clinical trial in high risk prostate cancer patients undergoing a prostatectomy. The aim of this trial will be to validate 99mTc-MIP-1404 uptake with the presence of prostate cancer in the prostate and lymph nodes as determined by histopathology. The Phase 2 trial is set to begin in the third quarter of 2012."

A second presentation titled, "[131I]MIP-1466, A Small Molecule Prostate-Specific Membrane Antigen (PSMA) Inhibitor for Targeted Radiotherapy of Prostate Cancer (PCa)" (Abstract 170), was delivered by Dr. Shawn M. Hillier, Associate Director, Biology. In this study 123I-MIP-1095, a high affinity ligand for PSMA in prostate cancer, has been shown to localize to radiologically-confirmed metastatic prostate cancer in men. That high expression of PSMA in prostate cancer led to the evaluation of the 131I analog of MIP-1095 (currently identified as MIP-1466) for therapeutic efficacy in a mouse tumor model of human prostate cancer. It was shown that 131 I-MIP-1466 dose dependently inhibited the growth of tumor xenografts in a PSMA specific manner at 131I doses that are clinically relevant. These data support clinical investigation of 131I-MIP-1466 as a targeted radiotherapeutic for the treatment of prostate cancer in men.

From now on, the compound currently identified as MIP-1466 will be known as 131I-MIP-1095. 131 I-MIP-1095 is structurally identical to 123I-MIP-1095 which was previously studied in humans for imaging prostate cancer. It is anticipated that an IND application for 131I-MIP-1095 will be filed with the U.S. Food and Drug Administration in the fourth quarter of this year, and that a Phase 1 dose escalation clinical trial will begin in the first quarter of 2013.

A third presentation titled, "Development of a Simple Kit for Tc-99m-MIP-1404, a Single Amino Acid Chelate (SAACII) Small Molecule Inhibitor of Prostate Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer" (Abstract 523), was given by Director of Radiochemistry and Production, Dr. Kevin P. Maresca. He reported on the development of a simple and efficient radiolabeling kit that could eventually be used to prepare 99mTc-MIP-1404 in radiopharmacies around the world for clinical studies and beyond. Optimization of the radiolabeling reaction conditions (time, temperature and concentration) of the final product was described. Radiochemical yield, radiochemical purity and specific activity were determined by HPLC analysis.

Dr. Maresca reported that the kit preparation method was shown to be robust and tolerant to a broad range of concentrations and volumes. The simple kit also allows the production of 99mTc-MIP-1404 in high radiochemical yield, radiochemical purity and specific activity. 99mTc-MIP-1404 demonstrated excellent radiochemical stability of greater than 90% after more than 24 hours at room temperature. Furthermore, this simple kit procedure has produced sterile, safe and high quality formulations of the 99mTc-MIP-1404 that maintain PSMA binding affinity and allows for vivid diagnostic images of prostate cancer as demonstrated in early clinical experience.

About Molecular Insight Pharmaceuticals, Inc. Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company focused on critical unmet diagnosis and therapeutic needs of the prostate cancer patient. The Company is targeting the development of a proprietary small molecule platform to improve detection and visualization of primary and metastatic prostate cancer and to provide a novel systemic radiotherapy for relapsed and metastatic prostate cancer. For further information, please visit the Company's website: http://www.molecularinsight.com.

See the original post here:

Molecular Insight Pharmaceuticals Presents Clinical Oncology Data at Society of Nuclear Medicine 2012 Annual Meeting

Keep Me in Mind – Hudson Taylor with Danny O’Reilly (The Coronas) – Video

Posted on by

13-06-2012 11:29 Hey Everyone, Sorry for the lag in uploading videos recently Lots of new stuff in the works and of course the release of our Debut EP 'Battles' which we are still rather vaguely saying will be released in the 'Centre of the Year' 😉 Thanks a million to Danny from The Coronas (Amazing band, also from Ireland)! Check them out here: and here: We're supporting Boyce Avenue in the Olympia in Dublin and at The Waterfront in Belfast on June 26th, 27th and 28th. Get tickets here: Follow us on TWITTER: We tweet daily. Tweet us saying hello! 😀 Like us on FACEBOOOK: 'Keep me in Mind' by Harry & Alfie Hudson-Taylor and Danny O'Reilly Chase your hope, is what you said to me, Irony that you could never see, I'm almost there but you're unaware how can I get it through to you, words fall short no matter what I do, You miss the point and it's unfair Won't you stand by my side (x2) Wooooo Won't you keep me in mind (x2) Wooooo I always want to put you first when I try it just gets worse. look at me, and tell me what you see honesty that only comes from me you missed the point and its unfair Thank you so so much for all your continued support! H & A x

Read the original:

Keep Me in Mind - Hudson Taylor with Danny O'Reilly (The Coronas) - Video

Graffiti Blackbook Sketch "Free Your Mind" – Video

Posted on by

13-06-2012 21:05 Please check out my facebook fan page, where I upload drawings that don't make it to youtube, if you'd like to contact me for any reason, or to just generally interact with me The piece in this says "michael" since I was bored and thought I'd do my name for once Leaving a rating is what cool kids do

Go here to see the original:

Graffiti Blackbook Sketch "Free Your Mind" - Video

Ways to get ads for your SME website

Posted on by

Having a website for your business to promote the products or services is always the icing on the cake. Your potential customer can have an online view of the product on your website and that you can convert it into a business opportunity

As long as you are running a website for glam models, this quote makes sense. Her story is so inspiring that you would consider launching a website that might make you a billionaire one day.

You are not a Cindy Margolis, nor are you a glam model or into her kind of a business. Your business and intention is to serve the common man, not the glam world.

So, when we talk about a business, startup or SME, the first thing that comes to our mind is a website. Having a website for your business to promote the products or services is always the icing on the cake. Your potential customer can have an online view of the product on your website and that you can convert it into a business opportunity.

So, when we talk about a website for your business, you must think a step ahead. That you make the most of that website to find additional revenues. A wonderfully-designed website with terrific content can even help you salvage your sinking business, as was the case with many companies in the past.

This is the era when digitalization has made website creation a simple and cost-effective affair, with Internet search giant Google offering free website for small and medium businesses (SMBs) in India. The success of this program has led it to roll out another service in Hyderabad, which enables small businesses in the city to upload 3D images of the interiors of their office, free of cost.

However, only having a simple website will not serve your cause. To make your business more popular and to reach out to more customers, you need advertisements on your site. For that to happen, the website should be unique in its looks and the user interface must be simple.

Here are some tips on how to get advertisements for your website:

Make your website popular

There are many ways to increase the reach of your site. Before landing direct ad deals, you will need to have a good amount of traffic on your site; about 1,000 unique visitors daily is good. If you are below that mark, you should focus on building traffic instead of looking for advertisers.

Original post:

Ways to get ads for your SME website

James Schramko Enriches Audience with Insights on Caching, Blogging and Pricing

Posted on by

In his recent Internet marketing news update on company website SuperFastBusiness.com, online business expert James Schramko issues various tips on topics such as caching, blogging and pricing. Besides this, he shares news on Wistia’s free video hosting offer and the upcoming free business conversion live training over at his coaching community Fast Web Formula.Sydney, Australia (PRWEB) June 15 ...

Go here to see the original:

James Schramko Enriches Audience with Insights on Caching, Blogging and Pricing

Cloud music is still the future for Apple, Amazon — really

Posted on by

Cloud music hasn't really caught on yet, but Apple and Amazon continue to bolster their services. The iPod proved that music drives hardware sales, and the big players can't afford to be without it.

Given recent headlines about cloud music, you might be forgiven for thinking that the feature is huge with consumers.

Word came Monday that Apple has finally caught up to Google and Amazon and begun to stream songs from the company's cloud. The following day, CNET broke news that Amazon is very close to reaching agreements with the top four record companies that would let it run a licensed cloud music service. Music industry sources also told CNET that Google and the labels continue to discuss cloud licenses.

Interesting news. Now here's the reality: Consumer adoption of cloud music has been lackluster, multiple music industry insiders tell me. The cloud has not yet led to a spike in interest or music sales, the sources told CNET. Data from The NPD Group supports that conclusion, said Russ Crupnick, the research's company's senior vice president and industry analyst.

"Despite the hullabaloo about cloud music, it hasn't gotten traction yet," Crupnick said, "I looked at our latest numbers and unreleased data, and only about 6 percent of the Internet population has even used something like [cloud music]."

That data suggests that music listeners are happy with the options they have now. Crupnick suspects that few people own enough music to max out their local storage, which would fuel the desire to store film and music libraries remotely. Representatives from Apple and Amazon did not respond to interview requests and Google declined to comment.

So why are the big music stores bothering to upgrade their music clouds?

One reason may be the iPod. Apple and the company's iconic digital music player proved music is a powerful driver of hardware sales. People want to listen to their jams on their mobile devices. Apple didn't care if the company's margins on song sales were thin. All the money was in selling iPods. Music has been a vital part of digital devices ever since. Keep in mind that in addition to being the Web's top retailer, Amazon is now very much a hardware maker.

The "cloud," of course, is the term used to describe where digital stuff "lives" when consumers store their files on a third party's servers rather than on their own PC or mobile device. While this type of data storage is old to techies, it is still relatively new to mainstream America. Heck, among the big three music stores, the cloud feature is barely a year old.

Amazon was first to launch cloud music with the initially unlicensed Cloud Drive and Cloud Player. Google later offered its own an unlicensed cloud-music service. Apple's system was the first to debut fully licensed.

Follow this link:

Cloud music is still the future for Apple, Amazon -- really

Evidence-Based Medicine Debate Series Tackles The Issue of Late-Stage Drug Development Failures In Alzheimer's Disease

Posted on by

NEW YORK, June 14, 2012 /PRNewswire/ -- The second installment of the successful EBM Debates series, launched in March 2012, will go live tomorrow, Friday, June 15, beginning at 12:30 PM Pacific, 2:30 PM Central, and 3:30 PM Eastern. This debate will cover a topic of increasing importance in the field of Alzheimer's disease research: "Why are there so many late-stage drug development failures in Alzheimer's disease?" Powered 4 Significance LLC, a Blue Ocean Pharma company, is hosting the virtual event that will have faculty joining from two locations Houston and Las Vegas.

(Logo: http://photos.prnewswire.com/prnh/20120125/NY41522LOGO)

We are excited to present our internationally recognized faculty for this debate, including the moderator and host, Marwan Sabbagh, MD, FAAN, and panelists Jeffrey Cummings, MD, ScD, Director of the Cleveland Clinic Lou Ruvo Center for Brain Health, Rachelle S. Doody, MD, PhD, Director of the Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine Department of Neurology, and Martin Farlow, MD, Associate Co-Director of the Indiana Alzheimer's Disease Center.

Panelists will discuss the topic at hand and answer questions submitted by the registered audience prior to and during the live debate. "Our goal is to shed light on why the research community and pharmaceutical companies are not experiencing more success in the development of Alzheimer's treatments," said Alden E. Masonis, PhD, co-founding partner of Powered 4 Significance and Blue Ocean Pharma.

Virtual participants are able to register for the event and submit questions through the EBM Debates website (www.ebmdebates.com). The debate will be archived and available for playback after the event.

Evidence-Based Medicine Debates (EBM Debates)The EBM Debates series has been created by Powered 4 Significance (www.powered4significance.com) based on an identified need for an open dialog among physicians involved in disease research and management, for a better understanding of important and controversial issues in disease diagnosis and treatment. The goal is to bring together researchers, thought leaders, and treating physicians to gain insight into the evidence base and enable informed decision-making. For more information on the EBM Debates, please visit http://www.ebmdebates.com.

Blue Ocean Pharma LLCBlue Ocean is on the forefront of developments in the pharmaceutical and healthcare sectors. Our services span the clinical development and commercialization needs of our clients and focus on supporting pharmaceutical, biotechnology, and device development, giving healthcare professionals the opportunity to optimize patient care and improve outcomes.

The Blue Ocean Pharma Group of companies consists of Percolation Communications LLC, i.e. Strategy LLC, and Powered 4 Significance LLC. Together, the Group offers complementary and unique services that provide synergistic support addressing client needs. To learn more about Blue Ocean Pharma, please visit us at http://www.blueoceanpharma.com.

Blue Ocean Pharma Contact: Marco Winkler +1 917 376 3019 mwinkler@blueoceanpharma.com

More:

Evidence-Based Medicine Debate Series Tackles The Issue of Late-Stage Drug Development Failures In Alzheimer's Disease